Physician

Harjot Maan, M.D.

According to 2025 Medicare claims, Harjot Maan, M.D. (NPI: 1093004566) practices micrographic dermatologic surgery in the Yuba City, CA market, with the plurality of this provider's patient population coming from Sutter, CA. This provider's primary affiliated billing organization is SUTTER VALLEY MEDICAL FOUNDATION (NPI: 1992939565; TIN: 680273974) and primary practice location at 95991-4123. Maan is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Maan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 794 traditional Medicare patients, billed 10,095 HCPCS/CPT codes, and received $1,999,550 in Medicare payments. The top billing code was 17312 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks). Part D data shows 488 prescription claims across 270 beneficiaries totaling $5,952 in drug costs, led by Doxycycline Monohydrate (Doxycycline Monohydrate). Open Payments data shows 4 records totaling $307. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $62,334 to $1,999,550. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $65,880 and ending at $5,952. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	115	739	$62,334
2017	586	6,915	$866,182
2018	705	7,764	$936,952
2019	733	7,824	$1,067,762
2020	699	7,048	$1,161,758
2021	451	4,523	$943,169
2022	558	6,552	$1,344,895
2023	598	7,473	$1,509,219
2024	794	10,095	$1,999,550

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	93	263	$65,880
2016	43	94	$18,759
2017	174	430	$31,523
2018	213	569	$89,793
2019	227	573	$137,708
2020	181	427	$109,635
2021	162	336	$79,096
2022	222	455	$84,151
2023	230	394	$66,452
2024	270	488	$5,952

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	407	891	$343
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	563	913	$305
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	409	651	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	525	979	$70
17000	Destruction of precancer skin growth, 1 growth	534	1,022	$36

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Doxycycline Monohydrate	Doxycycline Monohydrate	177	1,252	$2,040
Ondansetron Odt	Ondansetron	36	256	$415
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	65	240	$414
Erythromycin	Erythromycin Base	21	335	$301
Triamcinolone Acetonide	Triamcinolone Acetonide	17	575	$222

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$307	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Harjot Maan, M.D.?

Tedicare shows public-source Medicare data for Harjot Maan, M.D. (NPI 1093004566), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Harjot Maan, M.D. have ACO affiliation data?

Harjot Maan, M.D. is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Harjot Maan, M.D.?

Harjot Maan, M.D. is linked to SUTTER VALLEY MEDICAL FOUNDATION (billing NPI 1992939565) in the available physician profile data.

Does Harjot Maan, M.D. have Open Payments data?

Harjot Maan, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.